Clinical Review

New screening tests: HSV, CMV, HBV, HCV, parvovirus, and HIV

Author and Disclosure Information

Tips on choosing the right tests and getting valid results


 

References

Technology makes many things possible, but not without imposing new responsibilities. When it comes to viral infections, diagnosis through serology testing, antigen assays, or amplification techniques such as polymerase chain reaction (PCR) now is possible for a number of diseases, including:

  • herpes simplex virus (HSV),
  • cytomegalovirus (CMV),
  • hepatitis B and C viruses (HBV, HCV),
  • parvovirus B19 (B19), and
  • human immunodeficiency virus (HIV).

The responsibilities that come along with this ability: keeping up to date and selecting the most sensitive and specific test possible. This article reviews the latest tests and offers advice on their use in detecting 6 viruses.

How to pick the right test

When a patient’s presentation suggests viral infection, when something in her history raises a red flag, or when she reports possible exposure to a virus, the right test is critical to the diagnosis. The right test also helps prevent false positives and avoid confusion—but which test is best?

Which immunoglobulins matter?

Many of us have been taught that immunoglobulin M (IgM) correlates with acute infection, but that is not necessarily the case. Because of its high molecular weight, IgM is found most commonly in the intravascular compartment and is not transported to the fetus. IgM usually becomes apparent early during the course of infection. It has a half-life of 10 days and usually—but not always—regresses to undetectable levels over a few months.

The misconception that IgM is found only in acute infection and disappears within 3 months causes many clinicians to test for it and to misinterpret the results. In many cases, IgM fails to develop after acute infection. In others, it may persist for as long as 2 years after primary infection. It also can be detected with recurrent or reactivated infections.1

Immunoglobulin G (IgG) has a longer half-life (21 days) and is the most common immunoglobulin in humans. It is found in tissues and serum and readily crosses the placenta. It can be detected shortly after acute infection, exhibiting a steep rise and fall over several weeks after primary infection. IgG also is a sign of past infection.1

Telltale sign of acute infection

It now seems clear that an IgG antibody produced within the first months after primary infection binds to its antigen poorly. After this initial period, the IgG binds with greater intensity (ie, higher avidity) to that specific antigen (virus). Assays that measure this binding intensity are called avidity assays and are expressed as a percentage of IgG bound to the antigen after treatment with denaturing agents.

Avidity assays have been developed and studied for a variety of viruses.2 The detection of low-avidity IgG can be considered a more reliable sign of acute infection than IgM.

Herpes simplex virus

SERENA’S CASE

Monthly irritation and a vulvar lesion

Serena, 22, complains of irritation and pruritus that precede her period each month. She has tried treating herself with over-the-counter and prescription antifungal medication, without much relief. She presents to your office as an add-on patient and reports that the irritation started 1 day ago and usually lasts 7 days. Physical examination reveals a small area on the left vulva that is inflamed, with 2 small fissures. You obtain a vaginal pH, but it is normal, and there are negative findings on the wet prep.

In view of Serena’s history of recurrent symptoms and atypical lesions, recurrent herpes is a likely diagnosis, so you culture the lesion and order IgG type-specific serology for HSV 1 and 2. The culture is negative, but serology is positive for the HSV-2 antibody. Thus, serology confirms genital herpes.

Although Serena’s culture was negative, false-negative cultures are common with HSV, and serology testing usually is necessary to make the diagnosis of recurrent genital herpes.

HSV-2 is widespread: About 1 in 4 adults is infected. Of these, fewer than 1 in 10 is aware he or she has the virus. Thus, it makes sense to test for HSV-2 when physical findings suggest that it may be present.

Pages

Recommended Reading

Look for Neurologic Complications of Anesthesia
MDedge ObGyn
Screen-Detected Breast Ca Has Better Outcome
MDedge ObGyn
Weight Loss Reduces Breast Ca Risk in BRCA-Positive Women
MDedge ObGyn
Ductal Lavage Useful in Cases of Lobular Neoplasia
MDedge ObGyn
Data Watch: Diseases Women Fear Most
MDedge ObGyn
Anastrozole Use After Tamoxifen Tx Beneficial
MDedge ObGyn
Don't Stop Bisphosphonate Therapy After Early Bone Loss
MDedge ObGyn
Strategies to Reduce Steroid-Induced Fractures
MDedge ObGyn
Decision to Measure Bone Mineral Density Can Be Complex
MDedge ObGyn
WHO to Release Absolute Fracture Risk Index
MDedge ObGyn